AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 84 filers reported holding AMRYT PHARMA PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,408,864 | +8.1% | 192,995 | +2.5% | 0.40% | -8.6% |
| Q3 2022 | $1,303,000 | +5.8% | 188,300 | +6.8% | 0.44% | +16.4% |
| Q2 2022 | $1,232,000 | -2.8% | 176,309 | +15.0% | 0.38% | -27.8% |
| Q1 2022 | $1,268,000 | -66.5% | 153,267 | -56.2% | 0.52% | -65.8% |
| Q4 2021 | $3,782,000 | -39.2% | 350,213 | -32.2% | 1.53% | -56.4% |
| Q3 2021 | $6,218,000 | +12.3% | 516,221 | +13.1% | 3.52% | +42.3% |
| Q2 2021 | $5,538,000 | -7.5% | 456,537 | +6.2% | 2.47% | -24.4% |
| Q1 2021 | $5,988,000 | +5.1% | 429,863 | +6.8% | 3.27% | -1.4% |
| Q4 2020 | $5,700,000 | – | 402,556 | – | 3.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,912,000 | 26.04% |
| Stonepine Capital Management, LLC | 6,298,348 | $44,025,000 | 20.48% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,655,000 | 7.87% |
| Aquilo Capital Management, LLC | 1,866,652 | $13,048,000 | 4.45% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,144,000 | 2.04% |
| Global Frontier Investments LLC | 435,000 | $3,040,000 | 1.42% |
| Rubric Capital Management LP | 3,600,000 | $25,164,000 | 1.32% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $44,272,000 | 1.01% |
| Telemetry Investments, L.L.C. | 121,670 | $850,000 | 1.01% |
| Clearline Capital LP | 631,942 | $4,417,000 | 0.57% |